Enzymes
|
Serum
á Enzyme concentration = á reaction rate
|
Reagent
If enzyme > substrate, á substrate = á reaction rate
|
When substrate concentration reaches a
maximal value, higher concentration of substrate no longer results in
increased rate of reaction
|
Nonprotein entities
|
Organic compound
Ex. NADP
á Coenzyme = á Velocity
|
Inorganic ions
Alters spatial configuration of the enzyme
for proper substrate binding
Ex. Ca2+ (#1 activator), Zn2+
(LDH), Cl- (AMS), Mg2+ (CK, ALP)
|
Inorganic ion attached to a molecule
Ex. Catalase, cytochrome oxidase
|
Interferes with the enzymatic reactions
|
Binds to the active site of an enzyme
Reversible (Substrate > Inhibitor)
|
Binds to the allosteric site (cofactor site)
Irreversible
|
Binds to the enzyme-substrate complex
á Substrate = áES = áInhibition
|
Same catalytic reactions but slightly
different molecular structures
Fractionation of isoenzymes
|
37’C = optimum temperature for enzyme
activity
áTemperature = áReaction rate (ámovement of molecules)
|
Denaturation of enzymes
|
Inactivation of enzymes
|
For every 10OC increase in
temperature, there will be a two-fold increase in enzyme activity
|
Most physiologic reactions occur in the pH
range of 7-8
|
Enzymes: -20’C = for longer period of time
Substrate and Coenzymes: 2-8’C
LDH (LD4 & 5): Room temperature
|
Mostly increases enzyme concentration
|
Decreases enzyme concentration
|
1st digit: classification
2nd and 3rd digits:
subclass
4th digit(s): serial number
|
“OTHLIL”
Oxidoreductases
Transferases
Hydrolases
Lyases
Isomerases
Ligases
|
Redox reaction
Dehydrogenases:
-Cytochrome oxidase
-LDH
-MDH
-Isocitrate dehydrogenase
-G-6-PD
|
Transfer of a chemical group other than
hydrogen from 1 substrate to another
Kinases, Transaminases, Aminotransferases:
-CK
-GGT
-AST
-ALT
-OCT
|
Hydrolysis/splitting by addition of water
Esterases:
-ACP
-ALP
-CHS
-LPS
Peptidases:
-Trypsin
-Pepsin
-LAP
Glycosidases:
-AMS
-Galactosidases
|
Removal of groups w/o hydrolysis (product
contains double bonds)
Aldolase
Decarboxylases:
-Glutamate decarboxylase
-Pyruvate decarboxylase
-Tryptophan decarboxylase
|
Intramolecular arrangements
Glucose phosphate isomerase
Ribose phosphate isomerase
|
Joining of 2 substrate molecules
Synthases
|
Water-free cavity
Where the substrate interacts
|
Cavity other than the active site
May bind regulatory molecules
|
Coenzyme that is bound tightly to the enzyme
|
Apoenzyme + Prosthetic group
|
Inactive form of enzyme
|
Shape of the key (substrate) must fit into
the lock (enzyme)
|
Based on the substrate binding to the active
site of the enzyme
Acceptable theory
|
Enzymes catalyze reactions by lowering the
activation energy level that the substrate must reach for the reaction to
occur
|
Enzyme combines w/ only 1 substrate and
catalyzes only 1 reaction
|
Enzymes combine w/ all the substrates in a
chemical group
|
Enzymes reacting w/ specific chemical bonds
|
Reaction rate depends only on enzyme
concentration
Independent on substrate concentration
|
Reaction rate is directly proportional to
substrate concentration
Independent on enzyme concentration
|
Change in substrate concentration
Change in product concentration
Change in coenzyme concentration
|
1 micromole of substrate/minute
|
1 mole of substrate/second
|
Absorbance is made at 10-second intervals for
100 seconds
|
pH = 10.5
405nm
Electrophoresis:
(+) Liver ß Bone (Regan) ß Placenta ß Intestine (-)
Heat fractionation:
(Δ Stable) Regan ß Placenta ß Intestine ß Liver ß Bone (Δ Labile)
|
Inhibits Regan, placental and intestinal ALP
|
Inhibits Nagao ALP
|
Inhibits liver and bone ALP
|
Inhibits bone ALP
|
Low temperature = Increased ALP
1. Bowers and McComb (PNPP) – IFCC
recommended
2. Bessy, Lowry and Brock (PNPP)
3. Bodansky, Shinowara, Jones, Reinhart = BGP
(beta glycerophosphate)
4. King and Armstrong = PP (phenylphosphate)
5. Klein, Babson & Read = Buffered PPP
(phenolphthalein phosphate)
6. Huggins and Talalay = PPDP
(phenolphthalein diphosphate)
7. Moss = ANP (alpha naphthol phosphate)
|
Sprue
Hyperparathyroidism
Rickets (children) and osteomalacia (adults)
|
pH = 5.5
405nm
Sources: Prostate (major), RBC, platelets,
bone
|
Inhibited by L-tartrate ions
|
Inhibited by cupric and formaldehyde ions
|
Room temperature (1-2 hrs) = decreased ACP
Thymolphthalein monophosphate = specific
substrate, substrate of choice (endpoint)
Alpha-naphthyl phosphate = preferred for
continuous monitoring methods
1. Gutman and Gutman = PP
2. Shinowara = PNPP
3. Babsonm Read and Phillips = ANP
(continuous monitoring)
4. Roy and Hillman = Thymolphthalein
monophosphate (endpoint)
|
pH 7.5
340nm
Sources: Cardiac tissue > Liver > Skeletal
muscle > Kidney, pancreas, RBCs
|
pH 7.5
340nm
Major Source: Liver
|
1. Karmen method = Kinetic
2. Reitman and Frankel = Endpoint
-Color developer: DNPH
-Color intensifier: 0.4N NaOH
|
DeRitis ratio (ALT:AST) >1.0 = Acute
hepatitis (Highest)
á20x = viral or toxic hepatitis
Moderate elevation = chronic hepatitis,
hepatic cancer, IM
Slight elevation = Hepatic cirrhosis,
alcoholic hepatitis, obstructive jaundice
|
Smallest enzyme (appears in urine)
Earliest pancreatic marker
P3: most predominant pancreatic AMS isoenzyme
in AP
Isoenzymes:
S-type (ptyalin): anodal
P-type (amylopsin): cathodal
|
Samples w/ high activity of AMS should be
diluted w/ NaCl to prev. inactivation
Salivary AMS = inhibited by wheat germ lectin
Substrate: Starch
|
Reducing sugars produced
Classic reference method (SU)
|
Degradation of starch
|
Increase in color intensity
|
Continuous-monitoring technique
|
Late marker (AP)
Most specific pancreatic marker
|
Substrate: Olive oil/Triolein
1. Cherry Crandal (Reference method)
2. Tietz and Fiereck
3. Peroxidase coupling (most commonly used
method)
|
Lacks specificity
RBC: 150x LDH than in serum
Sources:
LD1 (α-HBD) and LD2 = Heart, RBC,
Kidneys
LD3 = pancreas, lungs, spleen
LD4 an LD5 = liver and
muscle
LD6 = alcohol dehydrogenase
|
1. Wacker method (forward/direct) = pH 8.8, 340
nm, most commonly used
2. Wrobleuski LaDue (reverse/indirect) = pH
7.2, 2x faster
3. Wrobleuski Cabaud
4. Berger Broida
|
Hepatic carcinoma and toxic hepatitis
|
Viral hepatitis and cirrhosis
|
Isoenzymes:
CK-BB = most anodal, brain
CK-MB = myocardium (20%)
CK-MM = least anodal, skeletal and smooth
muscles (Major, 94-100%)
|
Total CK: 50x URL (highest)
|
Most specific indicator of myocardial damage
(AMI)
Not elevated in angina
|
1. Tanzer-Gilbarg (forward/direct) = pH 9.0,
340nm
2. Oliver-Rosalki/ Rosalki & Hess
(reverse/indirect) = most commonly used method, faster reaction; pH 6.8,
340nm
|
Inside RBCs
Interferes w/ CK assay
Inhibited by adenosine monophosphate
|
Activate CK
|
Do not contain CK
|
Partially restore lost activity of CK
|
Reference method for CK
|
CKI (%) = CK-MB/Total CK x 100
|
Isoenzymes:
Aldolase A = Skeletal muscles
Aldolase B = WBC, liver, kidney
Aldolase C = brain tissue
|
Marker for hepatobiliary diseases and
infiltrative lesions of the liver
Methods:
1. Dixon and Purdon
2. Campbell, Belfield and Goldberg
|
Located in the canaliculi of the hepatic
cells
Differentates the source of an elevated ALP
level
Sensitive indicator of occult alcoholism
Increased:
Obstructive jaundice
Alcoholic hepatitis (most sensitive)
|
Substrate: gamma-glutamyl-p-nitroanilide
1. Szass
2. Rosalki and Tarrow
3. Orlowski
|
Monitor effects of relaxants
(succinylcholine) after surgery
Marker for organophosphate poisoning (Low
CHS)
Methods:
1. Ellman technic
2. Potentiometric
|
A.k.a. peptidyldipeptidase A or Kininase II
Converts angiotensin I à angiotensin II (lungs)
Indicator of neuronal dysfunction
(Alzheimer’s disease – CSF)
|
Ferrooxidase enzyme
|
For hepatobiliary diseases
|
Drug induced hemolytic anemia (primaquine,
antimalarial drug)
|
ALP = 30-90 U/L
ACP:
Total ACP (male) = 2.5-11.7 U/L
Prostatic ACP = 0-3.5 ng/mL
AST = 5-37 U/L
ALT = 6-37 U/L
AMS = 60-180 SU/dL (95-290 U/L)
LPS = 0-1.0 U/mL
LDH:
Forward = 100-225 U/L
Reverse = 80-280 U/L
|
Acute
Myocardial Infarction Markers
|
Myoglobin
|
Troponin T
|
Troponin I
|
CK-MB
|
AST
|
LD
|
1-3 h
|
3-4 h
|
3-6 h
|
4-8 h
|
6-8 h
|
12-24 h
|
5-12 h
|
10-24 h
|
12-18 h
|
12-24 h
|
24 h
|
48-72 h
|
18-30
h
|
7 d (10-14
d)
|
5-10 d
|
48-72 h
|
5 d
|
10-14 d
|
Acute
Pancreatitis Markers
|
Amylase
|
Lipase
|
2-12 h
|
6 h
|
24 h
|
24 h
|
3-5 d
|
7 d
|
Electrolytes
|
Equal no. of cations and anions
Balance of charges
|
Average water content of the human body
|
1/3 of total body water
|
2/3 of total body water
|
93% water (Plasma: 13% > Whole blood)
7% solutes: (Increased in dehydration)
-Proteins
-Glucose
-NPN
-Lipids
-Ions
|
Excretion of 10-20L H2O everyday
|
Sodium
Potassium
Chloride
|
EC = Na+ > Cl- > HCO3-
> Ca2+(5th) > iPO4
IC = K+ > Mg2+(4th)
|
Potassium
Calcium
Magnesium
|
Calcium
Magnesium (CK)
Zinc
Chloride (AMS)
Potassium
|
Magnesium
|
Magnesium
Phosphate
|
Bicarbonate
|
Magnesium
|
Major contributor of osmolality (92%,
together w/ Chloride and Bicarbonate)
á100 mg/dL glucose = â1.6 mmol/L sodium
|
áSodium
âPotassium = â Magnesium
|
â Sodium
|
Excess water loss
Decreased water intake
Hyperaldosteronism (Conn’s disease)
Hypothalamic disease (Chronic hypernatremia)
|
Renal failure
SIADH (increased water retention)
Marked hemolysis (dilutional effect)
<125 mmol/L = severe neuropsychiatric
symptoms
|
Major defense against hyperosmolality and
hypernatremia
1-2% water deficit = severe thirst
150-160 mEq/L Na+ = Moderate
deficit of water
>165 mEq/L Na+ = Severe water
deficit
|
Hyperlipidemia (turbidity)
Hyperproteinemia
|
1. FEP
2. AAS
3. ISE = Glass aluminum silicate
4. Colorimetry = Albanese Lein
|
Concentration in RBC is 105 mmol/L
Reciprocal relationship with H+
|
0.5% hemolysis = á 0.5 mmol/L
Gross hemolysis = á 30%
Serum K+ > Plasma K+
by 0.1-0.7 mmol/L because of platelets
(clot)
á10-20% in muscle activity
á0.3-1.2 mmol/L = mild to moderate exercise
á2-3 mmol/L = vigorous exercise; fist
clenching
|
Decreased resting membrane potential à incr. contractility à lack of muscle excitability
Decreased renal excretion (Dehydration, renal
failure, Addison’s disease)
Acidosis (DM)
Muscle injury
Spironolactone
|
Increased resting membrane potential à arrhythmia
Leads to hypomagnesemia
Vomiting
Diuretics
Cushing’s syndrome
Alkalosis
Insulin overdose
|
â pH by 0.1 = á K+ by 0.2-1.7 mmol/L
|
Lithium heparin plasma = preferred
1. FEP
2. AAS
3. ISE = Valinomycin gel
4. Colorimetry = Lockhead and Purcell
|
Chief counter ion of sodium in ECF
|
Chloride methods measure bromide and iodide
âCl- = áHCO3-
|
1. Schales and Schales:
-Mercurimetric titration
-Diphenylcarbazone
-Excess Hg++
-(+) Blue violet
2. Whiterhorn Titration method
-Mercuric thiocyanate
-Reddish complex
3. Ferric perchlorate
4. Cotlove chloridometer
-Coulometric amperometric titration
-Excess Ag++
5. ISE
-Ion exchange membrane
-Tri-n-octylpropylammonium chloride decanol
|
Renal tubular acidosis
Metabolic acidosis
Diabetes insipidus (Dehydration)
Prolonged diarrhea
|
Prolonged vomiting (âHCl)
Aldosterone deficiency (âNa+ = âCl- = áK+)
Metabolic alkalosis (áHCO3- = âCl-)
Marked hemolysis (dilutional effect)
|
99% à Bones
1% à ECF
Absorbed in the duodenum
Absorption is favored at an acidic pH
|
50% = Free/Ionized/Unbound/Active Calcium
40% = Protein-bound (Albumin)
10% = Complexed with anions
|
á Ca2+ = á absorption (intestine) and reabsorption
(kidney)
|
á Ca2+ = á resorption (bone) and reabsorption (kidney)
|
â Ca2+ = á urinary excretion (major net loss of
calcium)
|
Serum = specimen of choice
â Albumin (1g/dL) = â Ca2+ (0.8 mg/dL)
|
Acidosis (Ca2+: from Bones à Blood)
Cancer
Hyperthyroidism
Milk-alkali syndrome
|
Tetany
Alkalosis (Ca2+: from Blood à Bones)
Acute pancreatitis (Ca2+: binds to
damage pancreatic tissues)
|
Low PTH
Parathyroid gland disease
|
High PTH
Renal failure (á excretion)
|
1. Clark Collip precipitation method
-(+) Oxalic acid
-Renal calculi
2. Ferro Ham Chloranilic acid precipitation
method
-(+)Chloranilic acid
3. Colorimetric = Ortho-Cresolphthalein
complexone dyes
-Dye: Arzeno III
-8-hydroxyquinoline = chelates (inhibits) Mg2+
4. EDTA titration method (Bachra, Dawer and
Sobel)
5. AAS = Reference method
6. ISE = Liquid membrane
7. FEP
|
85% à Bones
15% à ECF (iPO4)
Maximally absorbed in the jejunum (Ca2+:
duodenum)
Trancellular shift: Once absorbed inside
cells, it no longer comes out à used for energy production
Dirunal variation: á late morning, â evening
Organic phosphate = principal anion within
cells
Inorganic phosphate = part of the blood
buffer (Measured in the clin.lab.)
|
55% = Free
35% = Complexed with ions
10% = Protein-bound
|
â PO4 = á Ca2+
|
á PO4 = â Ca2+
|
á PO4 (renal reabsorption)
|
Fasting is required (Nonfasting: â PO4)
|
Hypoparathyroidism
Renal failure
Hypervitaminosis D
|
Alcohol abuse = most common cause
Primary hyperparathyroidism
Avitaminosis D (Rickets, Osteomalacia)
|
Most accurate: unreduced phosphomolybdate
formation (340nm)
1. Fiske Subbarow Method (Ammonium molybdate
method)
-Reducing agents: Pictol, Elon, Senidine,
Ascorbic acid
-(+) Phosphomolybdenum blue
|
53% à Bones
46% à Muscles and soft tissues
1% à Serum and RBC
Vasodilator
|
55% = Free/Ionized/Physiologically active
30% = Protein-bound
10% = Complexed with ions
|
áMg2+ = á Ca2+ = â PO4
|
âMg2+ = â K+ = á Na+
|
Addison’s disease
Chronic renal failure
|
Acute renal failure
Chronic alcoholism
|
1. Calmagite
-(+) Reddish-violet complex
2. Formazen dye method
-(+) Colored complex
3. Magnesium Thymol blue method
-(+) Colored complex
4. AAS = reference method
5. Dye-lake Method
-Titan Yellow dye (Clayton Yellow or Thiazole
yellow)
|
90% of the total CO2
|
HCO3- diffuses out of
the cell in exchange for Cl- to maintain ionic charge neutrality
w/in the cell
|
Difference between unmeasured anions and
unmeasured cations
QC for ISE
|
Uremia/renal failure
Ketoacidosis
Lactic acidosis
Methanol poisoning
Ethanol poisoning
Ethylene glycol poisoning
Salicylate poisoning
|
Hypoalbuminemia
Hypercalcemia
Hyperlipidemia
Multiple myeloma
|
Defective gene: Cystic fibrosis
transmembranous conductance regulator (Chromosome 7)
Miconeum ileus (Infants)
Foul-smelling stool
URT infection
á Na+ and Cl-
|
Sweat inducer
|
Reference method (Sweat sodium and chloride)
|
Prooxidant
3-5g = Total body iron
Ferrous = Hgb
Ferric = Transferrin and Ferritin
|
1. Colorimetric = HCl and Ferrozine
-(+) Blue color
2. Anodic stripping voltammetry
|
Hemochromatosis
Viral hepatitis
Non-IDA
|
IDA
Malnutrition
Chronic infection
|
UIBC + Serum Iron
Increased: IDA, hepatitis, iron-supplemented
pregnancy
Decreased: Non-IDA, nephrosis
|
TIBC – Serum iron
Measure of reserve iron binding capacity of
transferrin
|
Index of iron storage
Increased: Iron overdose, hemochromatosis,
sideroblastic anemia
Decreased: IDA (lowest), malignancy, chronic
infection
|
TIBC (μg/dL) x 0.70 = mg/dL
|
Sodium 1/α Potassium
Potassium 1/α Hydrogen ion
Potassium α Magnesium
Magnesium α Calcium
Calcium 1/α Inorganic phosphate
Chloride 1/α Bicarbonate
|
Sodium:
Serum = 135-145 mmol/L
[Critical: 160 mmol/L and 120 mmol/L]
CSF = 136-150 mmol/L
Potassium:
Serum = 3.5-5.2 mmol/L
[Critical: 6.5 mmol/L and 2.5 mmol/L]
Chloride:
Serum = 98-107 mmol/L
Sweat = 5-40 mmol/L [Critical: >65 mmol/L]
Calcium:
Total = 8.6-10 mg/dL (adult) and 8.8-10.8
mg/dL (child)
Ionized = 4.6-5.3 mg/dL (adult) and 4.8-5.5
mg/dL (child)
[Critical: <7.5 mg/dL]
Inorganic Phosphate:
Adult = 2.7-4.5 mg/dL
Child = 4.5-5.5 mg/dL
Magnesium:
Serum = 1.2-2.1 mEq/L
Anion Gap:
w/ K+ = 10-20 mmol/L
w/o K+ = 7-16 mmol/L
Iron:
Male = 50-160 μg/dL
Female = 45-150 μg/dL
TIBC:
Adult = 245-425 μg/dL
>40 y.o. = 10-250 μg/dL
NB and Child = 100-200 μg/dL
% Transferrin Saturation = 20-50%
|